Biohaven Pharmaceutical Holding Company Ltd.

Biohaven Pharmaceutical Holding Company Ltd.verified

BHVN

Price:

$45.59

Market Cap:

$4.60B

Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavegepant that is in phase III clinical trials for acute and preventive treatment of migraine, as well as respiratory complications and non-migraine studies; and BHV-3100 for non-migraine indications. The company also offers Troriluzole for spinocerebellar ataxia and obsessive compulsive disorders, as well as Alzheimer diseases; BHV-0223, a product for amy...[Read more]

Industry

Biotechnology

IPO Date

2022-09-23

Stock Exchange

NYSE

Ticker

BHVN

The Dividend Yield as of November 2024 (TTM) for Biohaven Pharmaceutical Holding Company Ltd. (BHVN) is 0%

According to Biohaven Pharmaceutical Holding Company Ltd.’s latest financial reports and current stock price. The company's current Dividend Yield is 0%. This represents a change of 0% compared to the average of 0% of the last 4 quarters.

Biohaven Pharmaceutical Holding Company Ltd. (BHVN) Historical Dividend Yield (quarterly & annually)

How has BHVN Dividend Yield performed in the past?

The mean historical Dividend Yield of Biohaven Pharmaceutical Holding Company Ltd. over the last ten years is 0%. The current 0% Dividend Yield has changed 0% with respect to the historical average. Over the past ten years (40 quarters), BHVN's Dividend Yield was at its highest in in the March 2017 quarter at 0%. The Dividend Yield was at its lowest in in the March 2017 quarter at 0%.

Quarterly (TTM)
Annual

Average

0%

Median

0%

Minimum

0%

Maximum

0%

Biohaven Pharmaceutical Holding Company Ltd. (BHVN) Dividend Yield by Quarter and Year

Discovering the peaks and valleys of Biohaven Pharmaceutical Holding Company Ltd. Dividend Yield, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 0%

Maximum Annual Dividend Yield = 0%

Minimum Annual Increase = 0%

Minimum Annual Dividend Yield = 0%

Quarterly (TTM)
Annual
YearDividend YieldChange
20230%0%
20220%0%
20210%0%
20200%0%
20190%0%
20180%0%

Biohaven Pharmaceutical Holding Company Ltd. (BHVN) Average Dividend Yield

How has BHVN Dividend Yield performed in the past?

The current Dividend Yield of Biohaven Pharmaceutical Holding Company Ltd. (BHVN) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

0%

5-year avg

0%

10-year avg

0%

Biohaven Pharmaceutical Holding Company Ltd. (BHVN) Dividend Yield vs. Peers

How is BHVN’s Dividend Yield compared to its peers?

Biohaven Pharmaceutical Holding Company Ltd.’s Dividend Yield is less than Immunome, Inc. (0%), less than Inhibrx Biosciences, Inc. (6.04%), less than AgeX Therapeutics, Inc. (0%), less than Icosavax, Inc. (0%), less than Day One Biopharmaceuticals, Inc. (0%), less than Terns Pharmaceuticals, Inc. (0%), less than X4 Pharmaceuticals, Inc. (0%), less than Inozyme Pharma, Inc. (0%), less than Mereo BioPharma Group plc (0%), less than Apellis Pharmaceuticals, Inc. (0%), less than Blueprint Medicines Corporation (0%), less than Cerevel Therapeutics Holdings, Inc. (0%), less than Mirati Therapeutics, Inc. (0%), less than Amylyx Pharmaceuticals, Inc. (0%), less than Kymera Therapeutics, Inc. (0%), less than Revolution Medicines, Inc. (0%), less than C4 Therapeutics, Inc. (0%), less than Agios Pharmaceuticals, Inc. (0%), less than Nurix Therapeutics, Inc. (0%),

Build a custom stock screener for Biohaven Pharmaceutical Holding Company Ltd. (BHVN) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Biohaven Pharmaceutical Holding Company Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Biohaven Pharmaceutical Holding Company Ltd. (BHVN) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Biohaven Pharmaceutical Holding Company Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Dividend Yield?

How can you use the Dividend Yield?

What is Biohaven Pharmaceutical Holding Company Ltd.'s Dividend Yield?

How is the Dividend Yield calculated for Biohaven Pharmaceutical Holding Company Ltd. (BHVN)?

What is the highest Dividend Yield for Biohaven Pharmaceutical Holding Company Ltd. (BHVN)?

What is the 3-year average Dividend Yield for Biohaven Pharmaceutical Holding Company Ltd. (BHVN)?

What is the 5-year average Dividend Yield for Biohaven Pharmaceutical Holding Company Ltd. (BHVN)?

How does the current Dividend Yield for Biohaven Pharmaceutical Holding Company Ltd. (BHVN) compare to its historical average?